查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402028

2030 年智慧胰岛素笔针市场预测：按产品类型、适应症、可用性、连接性、最终用户和地区进行的全球分析

Smart Insulin Pens Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Usability, Connectivity, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球智慧胰岛素笔针市场规模为 1.1705 亿美元，预计预测期内复合年增长率为 13.8%，到 2030 年将达到 2.8932 亿美元。

智慧胰岛素笔针将传统胰岛素给药与现代技术结合，代表了糖尿病管理的革命性突破。此外，借助智慧型手机应用程式和蓝牙连接，这些笔可让使用者即时追踪和监测胰岛素给药。除了为患者和医疗保健专业人员提供有关胰岛素使用模式的有用见解之外，笔通常还包括资料储存功能、个人化胰岛素给药建议和频繁的给药提醒。

根据国际糖尿病联盟的数据，到 2021 年，大约有 5.37 亿成年人（20 至 79 岁）将患有糖尿病。预计2030年糖尿病患者总数将增加至6.43亿，2045年将增加至7.83亿。

提高患者的依从性和参与度

促进患者医嘱遵从性和参与糖尿病治疗的一个重要因素是使用智慧胰岛素笔针。即时监测、个体化给药建议和给药提醒等功能使患者能够积极参与他们的治疗计划。此外，透过促进控制感和课责，这些笔可以提高对建议的胰岛素治疗方案的医嘱遵从性，并降低与糖尿病管理不足相关的併发症的风险。

分配不公平和可近性有限

智慧胰岛素笔针的供应有限是一个主要障碍，特别是在资源有限的地区和开发中国家。这些尖端设备的潜在好处的实现因分布不均而受到阻碍，这可能导致获得医疗保健的机会存在差异。此外，由于基础设施、合格医疗人员的可用性和财务考量等问题，全球智慧胰岛素笔针的采用并不一致。

糖尿病发生率上升和人口高龄化

由于全球人口高龄化和糖尿病盛行率同步上升，智慧胰岛素笔针市场潜力巨大。老年人通常需要胰岛素治疗，而智慧笔易于使用的特点使他们感到舒适。此外，利用这些机会需要具体的行销计划和产品调整，以满足老年人的独特需求和偏好。

与传统胰岛素给药法的竞争

注射器和笔等传统胰岛素输送设备的持续广泛接受和使用对智慧胰岛素笔针构成了威胁。由于这些方法的既定用途和熟悉程度，采用更新的、技术先进的替代方案可能会遇到阻力。此外，为了应对这种危险，製造商应强调智慧胰岛素笔针与传统类型的独特优势和功能。

COVID-19 的影响：

智慧胰岛素笔针市场受到 COVID-19 爆发的多方面影响。儘管在疫情期间医疗保健行业的关注和创新有所增加，但优先事项的变化、医疗保健服务的中断以及经济的不确定性影响了市场动态。世界对医疗保健技术和基础设施（包括远端患者监护）的日益关注创造了智慧胰岛素笔针的机会。然而，供应链瓶颈、医疗措施延迟和卫生系统预算限制等问题阻碍了这些设备的普及。

智慧胰岛素笔针预计在预测期内以最高速度成长

由于其尖端功能和无缝技术集成，智慧胰岛素笔针预计将占据智慧胰岛素笔针市场的最大占有率。这些笔透过蓝牙连接和智慧型手机应用程式为用户提供给药提醒、资料追踪和即时监控。此外，智慧胰岛素笔针因其便利性和医嘱遵从性而成为患者和医疗保健提供者的首选，这也推动了普及。

预计居家照护产业在预测期内复合年增长率最高。

由于对居家医疗服务的需求不断增长以及以患者为中心的护理趋势，因此预计家庭护理设定行业的复合年增长率最高。随着医疗保健技术的进步和患者寻求更个体化的护理，居家照护环境提供了一个实用且舒适的环境来管理各种医疗需求。它还包括医疗设备的使用、长期状况监测和治疗提供。

占有率最大的地区：

由于医疗保健方面的大量投资、技术进步和强大的医疗保健基础设施，预计北美将占据最大的市场占有率。主要製药和医疗设备公司均位于美国，透过促进持续创新和推动市场成长，在该地区的主导地位中发挥关键作用。此外，由于政府倡议和有利的法规环境，北美市场的影响力越来越大。

复合年增长率最高的地区：

中东和非洲 (MEA) 地区的复合年增长率最高。该地区的医疗保健支出不断增加，对医疗保健基础设施的投资不断增加，人们对医疗保健解决方案的认识也不断提高。特别是在中东地区，各国正在改善医疗保健系统并引进尖端医疗技术。此外，该地区的显着增长受到慢性病患病率和改善医疗保健结果的愿望的影响。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球智慧胰岛素笔针市场：依产品

  • 智慧胰岛素笔针
  • 传统笔适配器
  • 其他产品

第六章全球智慧胰岛素笔针市场：按类型

  • 第一代笔
  • 第二代笔
  • 其他类型

第七章全球智慧型胰岛素笔针市场：依迹象分类

  • I型糖尿病
  • II型糖尿病
  • 其他适应症

第八章全球智慧型胰岛素笔针市场：依可用性

  • 填充
  • 可重复使用的

第九章全球智慧胰岛素笔针市场：互联性别

  • 蓝牙连接
  • USB连接
  • 其他连接

第10章全球智慧胰岛素笔针市场：依最终用户分类

  • 诊所及门诊手术中心
  • 电子商务
  • 线上销售
  • 家庭护理设置
  • 零售药房
  • 其他最终用户

第十一章全球智慧胰岛素笔针市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • Companion Medical Inc.
  • Eli Lilly & Company
  • Diamesco Co. Ltd.
  • Jiangsu Deflu Medical Device Co. Ltd.
  • Berlin-Chemie
  • Medtronic PLC
  • Emperra GmbH
  • Digital Medics Pty Ltd.
  • Novo Nordisk A/S
  • Sanofi
  • Pendiq
  • Bigfoot Biomedical
Product Code: SMRC24548

According to Stratistics MRC, the Global Smart Insulin Pens Market is accounted for $117.05 million in 2023 and is expected to reach $289.32 million by 2030 growing at a CAGR of 13.8% during the forecast period. Smart insulin pens, which combine conventional insulin delivery with contemporary technology, represent a revolutionary breakthrough in the management of diabetes. Moreover, with the help of smartphone applications and Bluetooth connectivity, these pens allow users to track and monitor their insulin dosages in real time. In addition to providing patients and healthcare professionals with useful insights into insulin usage patterns, the pens frequently include data storage capabilities, personalized insulin dose recommendations, and dose reminders.

According to International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Market Dynamics:

Driver:

Increased compliance and involvement of patients

An essential factor in encouraging patient adherence and involvement in diabetes care is the use of smart insulin pens. Individuals are empowered to actively engage in their treatment plans through features like real-time monitoring, personalized dosage recommendations, and dose reminders. Additionally, these pens help improve adherence to recommended insulin regimens by encouraging a sense of control and accountability, which lowers the risk of complications linked to inadequate diabetes management.

Restraint:

Inequitable distribution and limited accessibility

The restricted availability of smart insulin pens presents a major obstacle, especially in areas with limited resources and developing nations. The realization of the potential benefits these cutting-edge devices offer may be hampered by unequal distribution, which could lead to disparities in healthcare access. Furthermore, the inconsistent implementation of smart insulin pens worldwide is a result of issues with infrastructure, the availability of qualified medical personnel, and economic considerations.

Opportunity:

Rising rate of diabetes and aging population

The market for smart insulin pens has a lot of potential due to the aging population on a global scale and the concurrent rise in diabetes prevalence. Insulin therapy is frequently necessary for older people, and smart pens' user-friendly features can make them comfortable. Moreover, in order to take advantage of these opportunities, specific marketing plans and product adjustments are needed to cater to the unique requirements and preferences of senior citizens.

Threat:

Conventional insulin delivery methods competition

The widespread acceptance and continued use of traditional insulin delivery devices, like syringes and pens, pose a threat to smart insulin pens. Adopting newer, technologically advanced alternatives may be met with resistance due to the established use and familiarity of these methods. Additionally, in order to counter this danger, manufacturers should emphasize the unique benefits and features that differentiate smart insulin pens from conventional models.

COVID-19 Impact:

The market for smart insulin pens has been impacted in a number of ways by the COVID-19 pandemic. Despite increased focus and innovation in the healthcare sector during the pandemic, changes in priorities, disruptions in healthcare access, and economic uncertainty impacted market dynamics. Opportunities for smart insulin pens were created by the increased focus on healthcare technology and infrastructure worldwide, including remote patient monitoring. However, issues like hiccups in the supply chain, postponed healthcare initiatives, and budgetary limitations in healthcare systems hindered the uptake of these gadgets.

The Smart Insulin Pens segment is expected to be the largest during the forecast period

Due to their cutting-edge features and seamless technological integration, smart insulin pens are expected to hold the largest share of the market in the smart insulin pens market. These pens provide users with dose reminders, data tracking, and real-time monitoring through Bluetooth connectivity and smartphone applications. Moreover, smart insulin pens are a preferred option for both patients and healthcare providers due to their convenience and increased adherence, which have fueled their widespread adoption.

The Home Care Settings segment is expected to have the highest CAGR during the forecast period

Due to the growing demand for in-home medical services and the trend towards patient-centric healthcare, the home care settings segment is predicted to have the highest CAGR. Home care settings provide a practical and comfortable setting for managing a range of medical needs as healthcare technologies advance and patients seek more individualized care. Additionally, this covers using medical devices, monitoring long-term conditions, and administering treatments.

Region with largest share:

Due in large part to its substantial investments in healthcare, technological advancements, and strong healthcare infrastructure, North America is expected to hold the largest market share. Major pharmaceutical and medical device companies are based in the United States, which plays a significant role in the region's dominance by promoting ongoing innovation and propelling market growth. Furthermore, North America is becoming more and more prominent due to government initiatives and a favorable regulatory environment.

Region with highest CAGR:

The Middle East and Africa (MEA) region has the highest CAGR in the market. The area is seeing a rise in healthcare spending, a rise in investments in healthcare infrastructure, and a rise in awareness of healthcare solutions. Particularly in the Middle East, nations are improving their healthcare systems and embracing cutting-edge medical technology. Moreover, the region's significant growth is influenced by the prevalence of chronic diseases and the desire for improved healthcare outcomes.

Key players in the market:

Some of the key players in Smart Insulin Pens market include Companion Medical Inc., Eli Lilly & Company, Diamesco Co. Ltd., Jiangsu Deflu Medical Device Co. Ltd., Berlin-Chemie, Medtronic PLC, Emperra GmbH, Digital Medics Pty Ltd., Novo Nordisk A/S, Sanofi, Pendiq and Bigfoot Biomedical.

Key Developments:

In November 2023, Medtronic announced today that it launched its Penditure left atrial appendage (LAA) exclusion system in the U.S. Penditure, an implantable chip, comes pre-loaded on a single-use delivery system for LAA management during concomitant cardiac surgery procedures. Medtronic designed it with a curve to better match atrial anatomy and without fabric for atraumatic closure and reduced inflammation.

In August 2023, Novo Nordisk A/S has agreed to acquire Inversago Pharma for up to $1.075 billion. Inversago Pharma is developing CB1 receptor-based therapies for the potential treatment of obesity, diabetes and complications associated with metabolic disorders.

In July 2023, Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling.

Products Covered:

  • Smart Insulin Pens
  • Adaptors for Conventional Pens
  • Other Products

Types Covered:

  • First Generation Pens
  • Second Generation Pens
  • Other Types

Indications Covered:

  • Diabetes Type I
  • Diabetes Type II
  • Other Indications

Usabilities Covered:

  • Prefilled
  • Reusable

Connectivities Covered:

  • Bluetooth Connected
  • USB Connected
  • Other Connectivities

End Users Covered:

  • Clinics & Ambulatory Surgical Centers
  • E-Commerce
  • Online Sales
  • Home Care Settings
  • Retail Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Smart Insulin Pens Market, By Product

  • 5.1 Introduction
  • 5.2 Smart Insulin Pens
  • 5.3 Adaptors for Conventional Pens
  • 5.4 Other Products

6 Global Smart Insulin Pens Market, By Type

  • 6.1 Introduction
  • 6.2 First Generation Pens
  • 6.3 Second Generation Pens
  • 6.4 Other Types

7 Global Smart Insulin Pens Market, By Indication

  • 7.1 Introduction
  • 7.2 Diabetes Type I
  • 7.3 Diabetes Type II
  • 7.4 Other Indications

8 Global Smart Insulin Pens Market, By Usability

  • 8.1 Introduction
  • 8.2 Prefilled
  • 8.3 Reusable

9 Global Smart Insulin Pens Market, By Connectivity

  • 9.1 Introduction
  • 9.2 Bluetooth Connected
  • 9.3 USB Connected
  • 9.4 Other Connectivities

10 Global Smart Insulin Pens Market, By End User

  • 10.1 Introduction
  • 10.2 Clinics & Ambulatory Surgical Centers
  • 10.3 E-Commerce
  • 10.4 Online Sales
  • 10.5 Home Care Settings
  • 10.6 Retail Pharmacies
  • 10.7 Other End Users

11 Global Smart Insulin Pens Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Companion Medical Inc.
  • 13.2 Eli Lilly & Company
  • 13.3 Diamesco Co. Ltd.
  • 13.4 Jiangsu Deflu Medical Device Co. Ltd.
  • 13.5 Berlin-Chemie
  • 13.6 Medtronic PLC
  • 13.7 Emperra GmbH
  • 13.8 Digital Medics Pty Ltd.
  • 13.9 Novo Nordisk A/S
  • 13.10 Sanofi
  • 13.11 Pendiq
  • 13.12 Bigfoot Biomedical

List of Tables

  • Table 1 Global Smart Insulin Pens Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Smart Insulin Pens Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Smart Insulin Pens Market Outlook, By Smart Insulin Pens (2021-2030) ($MN)
  • Table 4 Global Smart Insulin Pens Market Outlook, By Adaptors for Conventional Pens (2021-2030) ($MN)
  • Table 5 Global Smart Insulin Pens Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Smart Insulin Pens Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Smart Insulin Pens Market Outlook, By First Generation Pens (2021-2030) ($MN)
  • Table 8 Global Smart Insulin Pens Market Outlook, By Second Generation Pens (2021-2030) ($MN)
  • Table 9 Global Smart Insulin Pens Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 10 Global Smart Insulin Pens Market Outlook, By Indication (2021-2030) ($MN)
  • Table 11 Global Smart Insulin Pens Market Outlook, By Diabetes Type I (2021-2030) ($MN)
  • Table 12 Global Smart Insulin Pens Market Outlook, By Diabetes Type II (2021-2030) ($MN)
  • Table 13 Global Smart Insulin Pens Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 14 Global Smart Insulin Pens Market Outlook, By Usability (2021-2030) ($MN)
  • Table 15 Global Smart Insulin Pens Market Outlook, By Prefilled (2021-2030) ($MN)
  • Table 16 Global Smart Insulin Pens Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 17 Global Smart Insulin Pens Market Outlook, By Connectivity (2021-2030) ($MN)
  • Table 18 Global Smart Insulin Pens Market Outlook, By Bluetooth Connected (2021-2030) ($MN)
  • Table 19 Global Smart Insulin Pens Market Outlook, By USB Connected (2021-2030) ($MN)
  • Table 20 Global Smart Insulin Pens Market Outlook, By Other Connectivities (2021-2030) ($MN)
  • Table 21 Global Smart Insulin Pens Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Smart Insulin Pens Market Outlook, By Clinics & Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Smart Insulin Pens Market Outlook, By E-Commerce (2021-2030) ($MN)
  • Table 24 Global Smart Insulin Pens Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 25 Global Smart Insulin Pens Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 26 Global Smart Insulin Pens Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 27 Global Smart Insulin Pens Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.